REFOSCO, FIORENZO
 Distribuzione geografica
Continente #
AS - Asia 3.242
NA - Nord America 1.905
SA - Sud America 663
EU - Europa 572
AF - Africa 58
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.448
Nazione #
US - Stati Uniti d'America 1.788
SG - Singapore 1.361
CN - Cina 708
BR - Brasile 514
VN - Vietnam 345
HK - Hong Kong 324
FR - Francia 197
KR - Corea 160
IT - Italia 105
BD - Bangladesh 81
NL - Olanda 68
CA - Canada 55
IN - India 54
GB - Regno Unito 53
AR - Argentina 41
JP - Giappone 40
ID - Indonesia 39
DE - Germania 31
CO - Colombia 30
EC - Ecuador 26
IL - Israele 21
FI - Finlandia 16
PH - Filippine 16
MX - Messico 15
VE - Venezuela 14
IQ - Iraq 13
PL - Polonia 13
RU - Federazione Russa 13
JM - Giamaica 12
TN - Tunisia 11
CL - Cile 10
ES - Italia 10
SA - Arabia Saudita 10
PE - Perù 9
UA - Ucraina 9
UY - Uruguay 9
UZ - Uzbekistan 9
ZA - Sudafrica 9
CR - Costa Rica 8
PK - Pakistan 8
GR - Grecia 7
PY - Paraguay 7
BE - Belgio 6
EG - Egitto 6
KE - Kenya 6
MY - Malesia 6
NI - Nicaragua 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
MA - Marocco 5
TR - Turchia 5
AT - Austria 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
KG - Kirghizistan 4
KW - Kuwait 4
NP - Nepal 4
NZ - Nuova Zelanda 4
BO - Bolivia 3
CI - Costa d'Avorio 3
ET - Etiopia 3
HN - Honduras 3
IE - Irlanda 3
JO - Giordania 3
LV - Lettonia 3
MK - Macedonia 3
RO - Romania 3
SC - Seychelles 3
SE - Svezia 3
SN - Senegal 3
TH - Thailandia 3
AG - Antigua e Barbuda 2
AL - Albania 2
AU - Australia 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
GE - Georgia 2
GP - Guadalupe 2
GT - Guatemala 2
KZ - Kazakistan 2
LT - Lituania 2
LU - Lussemburgo 2
LY - Libia 2
NO - Norvegia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HR - Croazia 1
Totale 6.436
Città #
Singapore 804
Santa Clara 501
Hefei 336
Hong Kong 321
San Jose 260
Seoul 159
Lauterbourg 154
Ashburn 109
Ho Chi Minh City 109
Beijing 92
Hanoi 89
Los Angeles 55
Dallas 41
São Paulo 39
Guangzhou 38
New York 21
Rio de Janeiro 18
Brasília 17
Minamishinagawa 17
Tokyo 17
Buffalo 15
Haiphong 15
Belo Horizonte 13
Bengaluru 13
Brooklyn 13
Milan 13
Toronto 13
Chicago 12
Da Nang 12
Frankfurt am Main 12
Helsinki 12
London 11
Orem 10
Phoenix 10
Warsaw 10
Biên Hòa 9
Can Tho 9
Council Bluffs 9
Hải Dương 9
Boardman 8
Curitiba 8
Montreal 8
Philadelphia 8
Tashkent 8
Amsterdam 7
City of London 7
Fortaleza 7
Guayaquil 7
Lima 7
Naples 7
Newark 7
Quito 7
Asunción 6
Athens 6
Brussels 6
Campinas 6
Cleveland 6
Fort Worth 6
Houston 6
Manaus 6
Montevideo 6
New Delhi 6
Riyadh 6
Rome 6
Salvador 6
San José 6
Shanghai 6
Thái Nguyên 6
Baku 5
Bogotá 5
Catania 5
Charlotte 5
Chennai 5
Detroit 5
Goiânia 5
Ha Long 5
Kingston 5
Managua 5
Miami 5
Nairobi 5
Ninh Bình 5
Padua 5
Poços de Caldas 5
Taboão da Serra 5
Turin 5
Uberlândia 5
Bandung 4
Bauru 4
Belém 4
Casablanca 4
Columbus 4
Contagem 4
Guarulhos 4
Hyderabad 4
Jacksonville 4
Las Vegas 4
Medellín 4
Memphis 4
Moscow 4
Ottawa 4
Totale 3.755
Nome #
Voltammetric behaviour of rhenium(I) complexes with phosphine and carbon monoxide ligands in acetonitrile solvent 86
Assessment of the best N3- donors in preparation of [M(N)(PNP)]-based (M=Tc-99m-; Re-188) target-specific radiopharmaceuticals: Comparison among succinic dihydrazide (SDH), N-methyl-S-methyl dithiocarbazate (HDTCZ) and PEGylated N-methyl-S-methyl dithiocarbazate (HO2C-PEG(600)-DTCZ) 83
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 77
Synthesis and characterization of novel 99-technetium(III) phosphine complexes. HPLC characterization and rat biodistribution of the Tc-99m analogs 76
Uncommon Anionic Dioxorhenium(V) and Neutral Monooxorhenium(V) Mixed-Ligand Complexes Containing Heterofunctionalized Phosphine Ligands: Syntheses and Structural Characterization 76
Technetium(V) and rhenium(V) complexes with Schiff-base ligands containing the ONNNO donor atom set. Crystal structure of [N,N?-3-azapentane-1,5-diylbis(salicylideneiminato)(3-)-O,O',N, N',N'']-oxotechnetium(V) 72
SYNTHESES AND STRUCTURAL CHARACTERIZATIONS OF 6-COORDINATE OXO-M(V) COMPLEXES (M=TC, RE) CONTAINING A TETRADENTATE P2N2-PHOSPHINO-AMIDO LIGAND 72
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET: physicochemical identification of by-products and degradation species 68
Monooxorhenium(V) complexes with the tridentate Schiff base N-(2-hydroxyphenyl)salicylideneimine 67
Novel TcP3X3 (XS, O) cores in Tc(III) chemistry 65
New approach to the chemistry of technetium(V) and rhenium(V) phenylimido complexes: novel [M(NPh)PNP]3+ metal fragments (M = Tc, Re; PNP = aminodiphosphine) suitable for the synthesis of stable mixed-ligand compounds 64
Synthesis and biological evaluation of new [Tc-99m(III)( PS)(2)(L)] mixed-ligand compounds (PS= phosphino-thiolate; L=dithiocarbamate), useful in design and development of Tc(III)radiopharmaceuticals 62
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand) 60
[Tc-99m(N)PNP]-moiety: a suitable scaffold for the developmant of radiolabeled probes for SPECT of multidrug resistance. In vitro study 59
Transglutaminase-mediated conjugation and nitride-technetium-99m labelling of a bis(thiosemicarbazone) bifunctional chelator 57
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 57
Phosphanyl-amino complexes of nickel(II): Synthesis and structure 55
Melanoma targeting with [Tc-99m(N)(PNP3)]-labeled alpha-melanocyte stimulating hormone peptide analogs: Effects of cyclization on the radiopharmaceutical properties 55
Synthesis and biological evaluation of new [99mTc(N)(PNPn)]2+-labeled cRGDfK peptide: preliminary studies. 55
Synthesis and characterization of rhenium(III) complexes with (Ph2PCH2CH2)(2)NR diphosphinoamine ligands 54
Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity 54
Tc-III-based mixed complexes for the design and the development of new SPECT tracers 53
Copper(I) heteroleptic 3+1 complexes: ligand effect on their in vitro cytotoxicity 52
Synthesis and characterization of novel hexacoordinated, asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy 52
Synthesis, Characterization and Crystal Structure of the Water Soluble Copper(I) Complex with Trisulfonated Triphenylphosphine 52
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 51
Studies of new [Tc(N)(PS)]-based mixed compounds as analogues of WAY 100635. 50
Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example. 49
Co-ordination of (o-aminophenyl)diphenylphosphine in complexes containing the [Mv = O]3+ (M = Tc or Re) core 49
Novel [Tc-99m(III)(PS)(2)(Ln)] Mixed-Ligand Compounds (PS = Phosphinothiolate; L = Dithiocarbamate) Useful in Design and Development of Tc-III-Based Agents: Synthesis, in Vitro, and ex Vivo Biodistribution Studies 49
Reactivity of the [M(PS)2](+) Building Block (M = Re(III) and (99m)Tc(III); PS = Phosphinothiolate) toward Isopropylxanthate and Pyridine-2-thiolate. 48
Melanoma targeting with [(TcN)-Tc-99m(PNP3)]-labeled alpha-MSH peptide analogs: Preliminary studies 48
Synthesis and characterization of novel tetrahedral copper(I) complexes comprising tridentate PNP-aminodiphosphines and tetradentate PN(X)P-substituted aminodiphosphines (X = O, S) 48
Electrospray mass spectrometry, mixed nitrido-Tc heterocomplexes and nuclear medicine 47
Synthesis and characterization of novel asymmetrical M(III) (M = Re, Tc-99g) complexes as models for the development of new potential tracers for SPECT imaging and radiotherapy 47
Radioactive Transition Metal Nitride Hetero-Complex 47
Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): Cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands 47
Chelating Systems for Tc-99m/Re-188 in the Development of Radiolabeled Peptide Pharmaceuticals 47
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 46
[MI(HB(pz)3)(P)] complexes (P = monodentate phosphine): comparison of the antiproliferative activity of silver and copper "3+1" mixed-ligand compounds 46
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imaging and radiotherapy. 46
Synthesis and Characterization of [MIII(PS)2(L)] mixed-ligand compounds (M = Re, 99Tc; PS= phosphino-thiolate; L= dithiocarbamate) as a model for the Development of New Agents for SPECT Imaging and Radiotherapy 46
Polydentate phosphinoamine ligands: a class of efficient chelating agents for the stabilization of various technetium(V) and rhenium(V) cores 45
Syntheses and characterisation of rhenium-(III) and -(V) complexes containing aminophosphine ligands. Crystal structures of [Re-V(OCl2)(OMe)L] and [Re-III(Cl3L)(PPh3)], L equals o-(diphenylphosphino)-N,N'-dimethylaniline 45
[188Re(N)(Cys~)(PNP)]+/0 mixed ligand compounds as models for the development of target specific agents 44
99mTc-Radiolabeled Peptides for Tumour Imaging: Present and Future 44
Synthesis and characterization of nitrido Tc(V) and Re(V) complexes with ferrocenedithiocarboxylate {FcCS(2)=[Fe(C5H4CS2)(C5H5)](-)} 44
Synthesis and characterization of technetium(V) oxo-complexes with quadridentate Schiff-base ligands: X-ray structures of ?-oxo-bis-{oxo[N,N?-propane-1,3-diylbis(salicylideneiminato)] technetium(V)} and chloro-oxo[N,N?-propane-1,3-diylbis(salicylideneiminato)]-technetium(V) 43
Insights into the failure of the potential, neutral myocardial imaging agent TcN-NOET : physico-chemical identification of by-products and degradation species 42
A NEW PHASE OF BIS[2-(DIPHENYLPHOSPHINO-K-P-PHENYLAZANIDO-K-N](ETHANOLATO)(OXO)-RHENIUM(V) 42
Synthesis, characterization and biological evaluation of [(188)Re(N)(cys similar to)(PNP)](+/0) mixed-ligand complexes as prototypes for the development of (188)Re(N)-based target-specific radiopharmaceuticals 42
Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals 42
Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules 41
Low-Valent Technetium Complexes with Aminodiphosphines 41
A New series of [99mTc(N)(DTC)(PNP)]+ complexes as potential myocardial imaging agents 41
Synthesis and characterization of novel asymmetrical M(III) (M = Re, 99gTc) complexes as models for the development of potential tracers for SPECT imagin and radiotherapy 41
The (Tc(N)(PNP))(2+) metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies 41
Synthesis and biological evaluation of [188Re(N)(CYS~)(PNP)]+/0 complexes as prototypes for the development of [188Re(N)(PNP)-based target vectors 40
Mixed-Ligand Rhenium-188 Complexes with Tetradentate/Monodentate NS3/P ('4 + 1') Coordination: Relation of Structure with Antioxidation Stability 40
Synthesis and characterization of a new series of asymmetrical M(III) (M = Re, 99gTc) complexes of the type [MIII(PS)2(L)], where PS = phosphinothiolate; L = dithiocarbamate (DTCn) or pyridine-2-thiolate (MPy) - Synthesis and characterization of novel asy 40
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 39
The [Tc(N)PNP] Metal Fragment Labeled Peptide for MC1 Receptors Imaging: preliminary studies 38
Tc and Re Nitrido Asymmetrical Heterocomplexes. A '2+2' Approach 38
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 37
Synthetic routes to mono-N-functionalized P2N2-ligands 37
The [99mTc(N)(PNP)]2+ Metal Fragment : A Technetium-Nitrido Synthon for use with Biologically Active Molecules. The N-(2-Methoxyphenyl)piperazyl-cysteine Analogues as Examples. 37
Technetium coordination chemistry; development of new backbones for 99mTc radiopharmaceuticals 36
Reactivity of Bi- and Tetra-Dentate Phosphinoamine Ligands Toward Technetium and Rhenium 36
Syntheses and characterization of amino and amido-imido technetium(V) and rhenium(V) complexes with (o-aminophenyl)diphenylphosphine-N,P. Crystal structures of [TcNCl{PPh2(C6H4NH2-2)} 2]Cl·MeCN and [Re{PPh2(C6H4N-2)}Cl2{PPh 2(C6H4NH-2}] 36
Complessi azoturo dissimmetrici monocationici di metalli di transizione radioattivi 35
Mixed ligand Tc-and Re-nitrido complexes for radiolabelling bioactive molecules 35
Syntheses and reactivity of sulphur rich Re(III) and Tc(III) complexes containing trithioperoxybenzoate, dithiobenzoate and dithiocarbamate ligands 35
ESI/MSn in the structural characterisation of some nitrido-Re heterocomplexes 35
The [Tc(N)PNP]2+ metal fragment labeled Cholecystokinin-8 (CCK8) peptide for CCK2 receptors imaging: preliminary biological studies 35
. [Re-188(N)(cys)(PNP)](+/0) mixed ligand compounds as models for target specific agents. 34
A mass spectrometric investigation of a series of [ReOX(PY)(2)] complexes containing bidentate phosphinophenolate and phosphinoamine ligands 34
Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines 34
Alternative Synthesis of Aminodiphosphines 34
The relationship between the electrospray ionization behaviour and biological activity of some phosphino Cu(I) complexes 34
Trigonal-Bypyramidal Tc(V) and Tc(III) Complexes with Mixed S,P-Bidentate Phosphine-Thiols 33
Neutral and cationic nickel (II) complexes of phosphino-amines: [NiCl2(PMe2Ph)(PNMe2)] and [NiCl(PMe2Ph) (PNMe2)]PF6 (PNMe2 = N,N?-dimethyl-2-(diphenylphosphino) aniline) 33
Design and Synthesis Of Tc- And Re-Based Metal-Fragments 33
SYNTHESIS AND CHARACTERIZATION OF TECHNETIUM(V) AND RHENIUM(V) OXO-COMPLEXES WITH SCHIFF-BASE LIGANDS CONTAINING THE ONN DONOR-ATOM SET - MOLECULAR-STRUCTURE OF TRANS-DICHLORO-OXO[1-(8'-QUINOLYLIMINOMETHYL)-2-NAPHTHOLATO-NN'O]TECHNETIUM(V) 33
Synthesis and Characterization of Novel Asymmetrical M(III) (M = Re, 99gTc) Complexes as Models for the Development of Potential Tracers for SPECT Imaging and Radiotherapy 33
Synthesis and characterization of [dichloro[hydrotris(1-pyrazolyl)borate]sulfido-technetium(V)] and [bis-(u-ethane-1,2-dithiolato)-bis-(ethene-1,2-dithiolato)-technetium(IV)] complexes. The first evidence of a terminal Tc=S multiple bond 32
The metal-fragment strategy for the construction of stable Tc and Re mixed-ligand compounds relevant to nuclear medicine 32
99mTc-nitrido complexes with a library of cysteine-biotin derivatives for pretargeting avidin-biotin immunoscintigraphy 32
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP=heterodiphosphane) 32
Synthesis of a series of Cu(I) derivatives containing PTA, PTAH and mPTA ligands and evaluation of their cytotoxic activity 32
Biological in vitro and in vivo studies of a series of new asymmetrical cationic [99mTc(N)(DTC-Ln)(PNP)]+ complex (DTC-Ln = alicyclic dithiocarbamate, PNP = bisphosphinoamine). 31
Synthesis and biodistribution in rats of a nitridotechnetium-99m radiopharmaceutical incorporating a benzodiazepine-receptor-specific ligand 31
Crystal structures of neutral trigonal bipyramidal [NiCl2(PMePh2)(PNMe2)]center dot 1/2CH(2)Cl(2) and cationic square planar [NiCl(PMePh2)(PNMe2)][PF6] complexes 30
Copper(I) and copper(II) complexes of polydentate phosphinoamines 30
Synthesis, in vitro and in vivo evaluation of new 99mTc-labeled cyclic RGDfK peptide monocationic complexes 30
SYNTHESIS AND CHARACTERIZATION OF NEUTRAL TECHNETIUM(III) COMPLEXES WITH MIXED S,P-BIDENTATE PHOSPHINE THIOLATE LIGANDS - CRYSTAL-STRUCTURE OF [TC(SCH2CH2PPH2)2(SCH2CH2PPH2O)] 30
A library of cysteine-biotine derivatives useful for pretargeting avidin-biotin radioimmunoscintigraphy 30
UNUSUAL SYNTHESIS AND X-RAY STRUCTURE OF CIS-DICHLORO[1,2-BIS(O-(DIPHENYLPHOSPHINO)PHENYL)ETHANE-1,2-DIOLATO(2-)]TECHNETIUM(IV) HEMIETHANOL SOLVATE 30
Avidin-biotin system: a small library of cysteine biotinylated derivatives designed for the [Tc-99m(N)(PNP)](2+) metal fragment 30
Synthesis of Asymmetrical Heterocomplexes of the [99mTc/99gTc(N)(PNP)]2+ Fragment with Cysteine-Functionalized Biotin 29
Cytotoxicity and mitochondrial disfunction induced by copper(I) complexes with tris(cyanoethyl)phosphine or tris(carboxyethyl)phosphine 29
Totale 4.486
Categoria #
all - tutte 25.782
article - articoli 15.850
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 322
Totale 41.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202457 0 0 0 0 0 0 0 0 2 0 53 2
2024/20252.149 16 12 184 93 418 94 20 86 25 59 599 543
2025/20263.554 200 331 392 599 578 130 511 175 151 176 81 230
2026/2027688 180 153 355 0 0 0 0 0 0 0 0 0
Totale 6.448